Spotlight

Spotlight

Debates, in-depth articles, and surprising profiles from ASH Clinical News

Gene Therapy: The Comeback Kid of Hematology Treatments?

Despite slow progress and unexpected setbacks, the future of gene therapy remains bright. Ashanthi de Silva was the first human to be treated successfully with...

Pulling Back the Curtain: Craig Cole, MD

In this edition, Craig Cole, MD, speaks about empowering patients to make treatment decisions, targeting racial disparities in myeloma, and more. Where did you grow...

Four of a Kind?

Soon, there may be as many as four JAK inhibitors available for patients with myelofibrosis. For many of his patients with myelofibrosis, ruxolitinib has been...

Unlocking Applications for RNA Sequencing

RNA sequencing is a genomics technology that gives scientists a transcriptome-wide view of gene expression and messenger RNA (mRNA) splicing. The tool is already...

Cellular Therapies Hold Promise in Myeloid Malignancies

There is hope that these therapies will improve outcomes, but development is still in early stages.  A recent spate of approvals of targeted treatments, such...

The Long Haul

For some people infected with COVID-19, the disease does not end with the swift resolution of all symptoms. Last year, Sudipto Mukherjee, MD, MPH, a...

Is Pretransplant Disease Reduction Necessary in MDS and AML?

For patients with myelodysplastic syndromes (MDS) or low-blast secondary acute myeloid leukemia (AML), allogeneic hematopoietic cell transplantation (AHCT) is the only potentially curative treatment...

Examining the Blood-Brain Barrier

The prognosis for patients with non-Hodgkin lymphoma (NHL) who develop central nervous system (CNS) relapse is dismal, and there are few clear answers about...

Pulling Back the Curtain: Vania Hungria, MD, PhD

In this edition, Vania Hungria, MD, PhD, describes her early interest in physical education instruction, her work with the International Myeloma Foundation in Latin...

Charting the Myeloma Immunotherapy Landscape

A bevy of forthcoming immunotherapies for multiple myeloma over the next few years raises hopes, as well as questions about combinations, sequencing, and potential...
Advertisement

Current Issue

May 2021 Volume 7 Issue 6

This issue provides an update on gene therapies in hematology, demystifies RNA sequencing, and more.

Block title